Genetic Test Can Identify Triple Negative Breast Cancer Treatment

$ 17.00

4.9
(795)
In stock
Description

A test including 53 genes can predict who will respond and who will not respond to triple negative breast cancer immunotherapy.

Triple Negative Breast Cancer - National Breast Cancer Foundation

Recent advances in therapeutic strategies for triple-negative breast cancer, Journal of Hematology & Oncology

Hereditary Breast Cancer

Inside Precision Medicine on LinkedIn: Precision Immuno-Oncology Start-Up Clasp Launches with $150M and…

What Is Triple-Negative Breast Cancer?

Frontiers Hypoxia: syndicating triple negative breast cancer against various therapeutic regimens

Long-term survival outcomes of triple-receptor negative breast cancer survivors who are disease free at 5 years and relationship with low hormone receptor positivity

Triple-Negative Breast Cancer Patients Should Undergo Genetic Screening - Mayo Clinic News Network

New Breast Cancer Drug Target Unveiled by IU Researchers

Cell Membrane Biomarkers in Triple-Negative Breast Cancer (TNBC) cells from transcriptomic analysis

Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease

Genetic Screening for Familial Hypercholesterolemia Improves Outcomes